1-8 of 8
Helena A. Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chromothripsis-Mediated Small Cell Lung Carcinoma

Open Access
Natasha Rekhtman, Sam E. Tischfield, Christopher A. Febres-Aldana, Jake June-Koo Lee, Jason C. Chang, Benjamin O. Herzberg, Pier Selenica, Hyung Jun Woo, Chad M. Vanderbilt, Soo-Ryum Yang, Fei Xu, Anita S. Bowman, Edaise M. da Silva, Anne Marie Noronha, Diana L. Mandelker, Miika Mehine, Semanti Mukherjee, Juan Blanco-Heredia, John J. Orgera, Gouri J. Nanjangud, Marina K. Baine, Rania G. Aly, Jennifer L. Sauter, William D. Travis, Omid Savari, Andre L. Moreira, Christina J. Falcon, Francis M. Bodd, Christina E. Wilson, Jacklynn V. Sienty, Parvathy Manoj, Harsha Sridhar, Lu Wang, Noura J. Choudhury, Michael Offin, Helena A. Yu, Alvaro Quintanal-Villalonga, Michael F. Berger, Marc Ladanyi, Mark T.A. Donoghue, Jorge S. Reis-Filho, Charles M. Rudin
Journal: Cancer Discovery
Cancer Discov (2025) 15 (1): 83–104.
https://doi.org/10.1158/2159-8290.CD-24-0286
Published: 13 January 2025
View articletitled, Chromothripsis-Mediated Small Cell Lung Carcinoma
Open the PDF for Chromothripsis-Mediated Small Cell Lung Carcinoma in another window
Includes: Supplementary data
Journal Articles

The Promise and Limitations of Neoadjuvant Immune-Checkpoint Blockade in Resectable Non–Small Cell Lung Cancer

Available to Purchase
Alissa J. Cooper, Helena A. Yu
Journal: Cancer Discovery
Cancer Discov (2023) 13 (11): 2306–2309.
https://doi.org/10.1158/2159-8290.CD-23-0949
Published: 01 November 2023
View articletitled, The Promise and Limitations of Neoadjuvant Immune-Checkpoint Blockade in Resectable Non–Small Cell Lung Cancer
Open the PDF for The Promise and Limitations of Neoadjuvant Immune-Checkpoint Blockade in Resectable Non–Small Cell Lung Cancer in another window
Journal Articles

Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET-Amplified Non–Small Cell Lung Cancer: TATTON

Open Access
Ryan J. Hartmaier, Aleksandra A. Markovets, Myung Ju Ahn, Lecia V. Sequist, Ji-Youn Han, Byoung Chul Cho, Helena A. Yu, Sang-We Kim, James Chih-Hsin Yang, Jong-Seok Lee, Wu-Chou Su, Dariusz M. Kowalski, Sergey Orlov, Song Ren, Paul Frewer, Xiaoling Ou, Darren A.E. Cross, Nisha Kurian, Mireille Cantarini, Pasi A. Jänne
Journal: Cancer Discovery
Cancer Discov (2023) 13 (1): 98–113.
https://doi.org/10.1158/2159-8290.CD-22-0586
Published: 09 January 2023
View articletitled, Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET-Amplified Non–Small Cell Lung Cancer: TATTON
Open the PDF for Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET-Amplified Non–Small Cell Lung Cancer: TATTON in another window
Includes: Supplementary data
Journal Articles

Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer

Open Access
Anup Kumar Biswas, Seoyoung Han, Yifan Tai, Wanchao Ma, Courtney Coker, S. Aidan Quinn, Ahmad Rushdi Shakri, Timothy James Zhong, Hanna Scholze, Galina G. Lagos, Angeliki Mela, Katia Manova-Todorova, Elisa de Stanchina, Adolfo A. Ferrando, Cathy Mendelsohn, Peter Canoll, Helena A. Yu, Paul K. Paik, Anjali Saqi, Catherine A. Shu, Mark G. Kris, Joan Massague, Swarnali Acharyya
Journal: Cancer Discovery
Cancer Discov (2022) 12 (4): 1002–1021.
https://doi.org/10.1158/2159-8290.CD-21-0910
Published: 01 April 2022
View articletitled, Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer
Open the PDF for Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer

Open Access
Pasi A. Jänne, Christina Baik, Wu-Chou Su, Melissa L. Johnson, Hidetoshi Hayashi, Makoto Nishio, Dong-Wan Kim, Marianna Koczywas, Kathryn A. Gold, Conor E. Steuer, Haruyasu Murakami, James Chih-Hsin Yang, Sang-We Kim, Michele Vigliotti, Rong Shi, Zhenhao Qi, Yang Qiu, Lihui Zhao, David Sternberg, Channing Yu, Helena A. Yu
Journal: Cancer Discovery
Cancer Discov (2022) 12 (1): 74–89.
https://doi.org/10.1158/2159-8290.CD-21-0715
Published: 01 January 2022
View articletitled, Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
Open the PDF for Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation

Available to Purchase
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A. Zhan, Maysun M. Hasan, Shweta S. Chavan, Fanli Meng, Fathema Uddin, Parvathy Manoj, Mark T.A. Donoghue, Helen H. Won, Joseph M. Chan, Metamia Ciampricotti, Andrew Chow, Michael Offin, Jason C. Chang, Jordana Ray-Kirton, Sam E. Tischfield, Jacklynn Egger, Umesh K. Bhanot, Irina Linkov, Marina Asher, Sonali Sinha, Joachim Silber, Christine A. Iacobuzio-Donahue, Michael H. Roehrl, Travis J. Hollmann, Helena A. Yu, Juan Qiu, Elisa de Stanchina, Marina K. Baine, Natasha Rekhtman, John T. Poirier, Brian Loomis, Richard P. Koche, Charles M. Rudin, Triparna Sen
Journal: Cancer Discovery
Cancer Discov (2021) 11 (12): 3028–3047.
https://doi.org/10.1158/2159-8290.CD-20-1863
Published: 02 December 2021
View articletitled, Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
Open the PDF for Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation in another window
Includes: Supplementary data
Journal Articles

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Free
Bob T. Li, Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai, Sophie Shifman, Hai-Yan Tu, Mackenzie L. Myers, Chongrui Xu, Marissa Mattar, Inna Khodos, Megan Little, Besnik Qeriqi, Gregory Weitsman, Clare J. Wilhem, Alshad S. Lalani, Irmina Diala, Rachel A. Freedman, Nancy U. Lin, David B. Solit, Michael F. Berger, Paul R. Barber, Tony Ng, Michael Offin, James M. Isbell, David R. Jones, Helena A. Yu, Sheeno Thyparambil, Wei-Li Liao, Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis-Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2020) 10 (5): 674–687.
https://doi.org/10.1158/2159-8290.CD-20-0215
Published: 01 May 2020
View articletitled, HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers
Open the PDF for HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers in another window
Includes: Supplementary data
Journal Articles

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

Free
Emmet J. Jordan, Hyunjae R. Kim, Maria E. Arcila, David Barron, Debyani Chakravarty, JianJiong Gao, Matthew T. Chang, Andy Ni, Ritika Kundra, Philip Jonsson, Gowtham Jayakumaran, Sizhi Paul Gao, Hannah C. Johnsen, Aphrothiti J. Hanrahan, Ahmet Zehir, Natasha Rekhtman, Michelle S. Ginsberg, Bob T. Li, Helena A. Yu, Paul K. Paik, Alexander Drilon, Matthew D. Hellmann, Dalicia N. Reales, Ryma Benayed, Valerie W. Rusch, Mark G. Kris, Jamie E. Chaft, José Baselga, Barry S. Taylor, Nikolaus Schultz, Charles M. Rudin, David M. Hyman, Michael F. Berger, David B. Solit, Marc Ladanyi, Gregory J. Riely
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2017) 7 (6): 596–609.
https://doi.org/10.1158/2159-8290.CD-16-1337
Published: 01 June 2017
View articletitled, Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
Open the PDF for Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies in another window
Includes: Supplementary data